Haleos Labs Limited (NSE:SMSLIFE)
1,122.40
-18.20 (-1.60%)
Oct 24, 2025, 3:29 PM IST
Haleos Labs Revenue
Haleos Labs had revenue of 825.05M INR in the quarter ending June 30, 2025, a decrease of -10.85%. This brings the company's revenue in the last twelve months to 3.35B, up 3.34% year-over-year. In the fiscal year ending March 31, 2025, Haleos Labs had annual revenue of 3.45B with 12.67% growth.
Revenue (ttm)
3.35B
Revenue Growth
+3.34%
P/S Ratio
1.01
Revenue / Employee
5.65M
Employees
592
Market Cap
3.39B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 3.45B | 387.65M | 12.67% |
| Mar 31, 2024 | 3.06B | -96.02M | -3.04% |
| Mar 31, 2023 | 3.16B | -345.11M | -9.86% |
| Mar 31, 2022 | 3.50B | 844.79M | 31.81% |
| Mar 31, 2021 | 2.66B | 48.11M | 1.84% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 537.77B |
| Aurobindo Pharma | 320.25B |
| Cipla | 274.80B |
| Zydus Lifesciences | 236.08B |
| Apollo Hospitals Enterprise | 225.51B |
| Glenmark Pharmaceuticals | 134.56B |
| Alkem Laboratories | 133.04B |
| Mankind Pharma | 129.10B |